Integra LifeSciences Holdings Corporation (IART)
NASDAQ · Healthcare
Integra LifeSciences Holdings Corporation EBITDA 2016–2025
Integra LifeSciences Holdings Corporation annual/quarterly ebitda history and growth rate from 2016 to 2020. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Integra LifeSciences Holdings Corporation ebitda for the quarter ending March 31, 2020 was 56.3 M, a 5.30% decrease year-over-year.
- Integra LifeSciences Holdings Corporation ebitda for the twelve months ending March 31, 2020 was 198.0 M, a 88.06% increase year-over-year.
- Integra LifeSciences Holdings Corporation annual ebitda for 2019 was 203.2 M, a 8.35% decrease from 2018.
- Integra LifeSciences Holdings Corporation annual ebitda for 2018 was 221.7 M, a 65.78% increase from 2017.
- Integra LifeSciences Holdings Corporation annual ebitda for 2017 was 133.7 M, a 28.86% decrease from 2016.
- Integra LifeSciences Holdings Corporation annual ebitda for 2016 was 188.0 M.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Integra LifeSciences Holdings Corporation EBITDA — FAQ
Integra LifeSciences Holdings Corporation (IART) ebitda over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IART's ebitda history?
The chart and table above show Integra LifeSciences Holdings Corporation's ebitda by year and by quarter, including the growth rate.